Expand TYRA Menu
TYRA MENU

TYRA Stock Posts


Unusual Option Volume

TYRA Tyra Biosciences36.38-0.77 (-2.1%)

Tyra Biosciences trades 3,409 contracts.
View Details...
Unusual Option Volume

TYRA Tyra Biosciences30.48-0.54 (-1.7%)

Tyra Biosciences trades 2,238 contracts.
View Details...
Unusual Option Volume

TYRA Tyra Biosciences30.70-0.12 (-0.4%)

Tyra Biosciences trades 2,523 contracts. The highest volume is in the 15-May-26 20 puts.
View Details...
Unusual Option Volume

TYRA Tyra Biosciences18.12-1.77 (-8.9%)

Tyra Biosciences trades 2,474 contracts. The highest volume is in the 15-Nov-24 25 calls, which is 38.0% above the current price.
View Details...
TYRA #TyraBiosciences stock declines -12.5% in premarket,

Premarket Decliner

TYRA Tyra Biosciences28.61+0.37+1.3%

Premarket:25.02-3.59 (-12.5%)

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)

PRNewswireThu, 24-Oct 6:21 PM
Unusual Option Volume

TYRA Tyra Biosciences28.31+0.98 (+3.6%)

Tyra Biosciences trades 3,011 contracts. The company has the following event: 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) on Oct 25, 2024.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes